Close

Goldman Sachs Starts Acadia Pharmaceuticals (ACAD) at Neutral

Go back to Goldman Sachs Starts Acadia Pharmaceuticals (ACAD) at Neutral
Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) Delayed: 16.59 -0.15 (0.9%)
Previous Close $16.74    52 Week High $42.49 
Open $16.81    52 Week Low $16.64 
Day High $16.86    P/E N/A 
Day Low $16.55    EPS $-0.42 
Volume 1,296,887